The need for a task force was born out of a September 2019 symposium, “Gene Editing in Livestock: Looking to the Future,” which the two associations organized. During that event, 23 of the nation’s leading experts from academia, government, industry, and professional groups gathered to examine a series of questions ranging from the nature and safety of this promising technology to its ethical implications.
Symposium participants concluded that work with animal and plant genomes has vast potential for limiting disease and increasing productivity, but agreed that appropriate regulatory processes should be thoroughly considered and structured. Currently the Food and Drug Administration regulates genetic work on food animals as an “animal drug” and the USDA regulates these technologies with crops.
“This is a very promising area of biotechnology that has the potential to unleash enormous progress in terms of food production and security,” said Dr. Noelle Cockett, President of Utah State University and a renowned geneticist who is leading the task force. “Last fall’s symposium featured a series of presentations and discussions which identified and explored important questions and implications related to this emerging technology. These need to be thoughtfully considered and transformed into policy and regulatory recommendations. That’s the goal of this task force.”
To develop a task force, the AAVMC and APLU established a steering committee, which put out a call for nominations. That steering committee selected six people from academia to serve on the task force: Dr. Jon Oatley, Washington State University; Dr. Bhanu Telugu, Virginia-Maryland College of Veterinary Medicine; Dr. Londa Nwadike, University of Missouri; Dr. Jonathan Beever, University of Tennessee; Dr. Rex Dunham, Auburn University; and Dr. James Murray, University of California, Davis.
The task force will also include Dr. Andrew Rowan, Wellbeing International; Dr. Kathy Simmons, National Cattlemen’s Beef Association; Clint Nesbitt, Biotechnology Innovation Organization (BIO); and a liaison to the Center for Food Integrity. The task force will be chaired by Dr. Cockett.
“The potential for gene editing to dramatically boost food security globally and reduce the burden on natural resources is enormous, but it must be done carefully and ethically,” APLU President Peter McPherson said. “We are very pleased to partner with AAVMC on this task force, which is bringing together some of the foremost leaders in the world to help recommend a path for government to take to regulate this field in a way that protects all involved while allowing the science to flourish.”
The task force is expected to conduct its first virtual meeting in early summer, and in-person meetings will be held following the relaxation of pandemic-induced social distancing protocols.
The APLU and the AAVMC decided to take action in this area following inquiries from members of Congress to Food and Drug Administration Acting Commissioner Norman E. Sharpless concerning current regulatory processes. That provided the impetus for the AAVMC and the APLU to organize the fall 2019 symposium for leading scientists and other scholars.
“The symposium we presented last fall in partnership with APLU was a big step forward in a very important process,” said AAVMC CEO Dr. Andrew T. Maccabe. “We’re very grateful to the group of respected experts who have agreed to help us move this project forward. We’re also pleased to have the opportunity to collaborate with APLU on a large scale program that has such vast implications for agricultural productivity and disease prevention.”
Discussions and presentations held over the September 2019 day-and-a-half conference explored different facets of the gene-editing issue from a public policy perspective. Conference sessions included Science and Research, Industry Perspective, Bioethics, Public Policy and Regulation, and Communication and Public Engagement.
The APLU and the AAVMC previously teamed up on a multi-year effort designed to address the growing antimicrobial resistance problem. That led to the establishment of the National Institute of Antimicrobial Resistance Research and Education, which is based at Iowa State University and operates in collaboration with a consortium of partner universities and medical institutions.
To examine the program and learn more about the people who participated, please click here.